MicroRNA-145 inhibits the proliferation, migration and invasion of the human TCA8113 oral cancer line

Oncology Letters

Volumn 6, Issue 6, 2013, Pages 1636-1640

  Shao, Yuan ^a   Zhang, Shao Qiang ^a   Quan, Fang ^a   Zhang, Peng Fei ^a   Wu, Sheng Li ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Invasion; MicroRNA 145; Migration; Oral cancer cell; Proliferation

Indexed keywords

MICRORNA 145;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CANCER; POLYMERASE CHAIN REACTION;

EID: 84886793015     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1621     Document Type: Article

References (30)

1. Warnalulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45: 309-316, 2009.
2. Hernández-Guerrero JC, Jacinto-Alemán LF, Jiménez-Farfán MD, Macario-Hernández A, Hernández-Flores F and Alcántara-Vázquez A: Prevalence trends of oral squamous cell carcinoma. Mexico City's General Hospital experience. Med Oral Patol Oral Cir Bucal 18: e306-e311, 2013.
3. Bagan J, Sarrion G and Jimenez Y: Oral cancer: clinical features. Oral Oncol 46: 414-417, 2010
4. Shah JP and Gil Z: Current concepts in management of oral cancer-surgery. Oral Oncol 45: 394-401, 2009.
5. Kurita H, Nakanishi Y, Nishizawa R, Xiao T, Kamata T, et al: Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma. Oral Oncol 46: 814-817, 2010.
6. Pérez I, Varona A, Blanco L, Gil J, Santaolalla F, et al: Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma. Head Neck 31: 1335-1340, 2009.
7. Yi R and Fuchs E: MicroRNAs and their roles in mammalian stem cells. J Cell Sci 124: 1775-1783, 2011.
8. Valastyan S, Chang A, Benaich N, Reinhardt F and Weinberg RA: Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev 25: 646-659, 2011.
9. Hou J, Lin L, Zhou W, Wang Z, Ding G, et al: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243, 2011.
10. Hu J, Guo H, Li H, Liu Y, Liu J, et al: MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4. PLoS One 7: e45965, 2012.
11. Hammond SM: MicroRNAs as tumor suppressors. Nat Genet 39: 582-583, 2007.
12. Sachdeva M and Mo YY: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 70: 378-387, 2010.
13. Cho WC, Chow AS and Au JS: Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 45: 2197-2206, 2009.
14. Guo L, Liu Y, Bai Y, Sun Y, Xiao F and Guo Y: Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur J Cancer 46: 1692-1702, 2010.
15. Yu Y, Chen W, Zhang Y, Hamburger AW, Pan H and Zhang Z: Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer. Int J Cancer 120: 1909-1913, 2007.
16. Cho WC: MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42: 1273-1281, 2010.
17. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, et al: miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
18. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, et al: miR-145 participates with Tp53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ 17: 246-254, 2010.
19. Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A and Lund AH: MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 5: e8836, 2010.
20. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, et al: MiR-145, miR-133a and miR-133b: Tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
21. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology 77: 12-21, 2009.
22. Yu T, Wang XY, Gong RG, Li A, Yang S, et al: The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 28: 64, 2009.
23. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, et al: p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106: 3207-3212, 2009.
24. Chen X, Gong J, Zeng H, Chen N, Huang R, et al: MicroRNA-145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res 70: 2728-2738, 2010.
25. Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, et al: Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int J Oncol 39: 409-415, 2011.
26. Chung YW, Bae HS, Song JY, Lee JK, Lee NW, et al: Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patient. Int J Gynecol Cancer 23: 673-679, 2013.
27. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T and Baserga R: Micro RNA-145 targets in insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 282: 32582-32590, 2007.
28. Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, et al: The functional significance of microRNA-145 in prostate cancer. Br J Cancer 103: 256-264, 2010.
29. Wang S, Bian C, Yang Z, Bo Y, Li J, et al: miR-145 inhibits breast cancer cell growth through RTKN. Int J Oncol 34: 1461-1466, 2009.
30. Xu N, Papagiannakopoulos T, Pan G, Thomson JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658, 2009.